PRIVACY POLICY

Last updated: 25 June 2026

This Privacy Policy explains how MoleSense Sàrl (“MoleSense”, “we”, “us” or “our”) collects, uses and protects personal data when you visit or interact with our website at www.molesense.ch.

This Privacy Policy applies to our public website only. It does not apply to any future product, mobile application, wearable device, clinical study, patient service, research programme or health-data processing unless we provide a separate privacy notice for those activities.

1. Who we are

The data controller responsible for the processing of personal data through this website is:

MoleSense Sàrl
Route de la Corniche 5
1066 Epalinges
Switzerland

UID: CHE-338.667.467
Commercial register number: CH-550.1.252.018-7

For privacy-related questions or requests, you can contact us at:

contact@molesense.ch

2. What personal data we collect

We collect limited personal data through our website.

When you contact us through a website form, we may collect:

  • your full name;
  • your email address;
  • any other information you choose to include in your message or form submission.

We do not currently collect health data, patient data, biomarker data, wearable-device data, app data, product usage data or clinical data through this website.

Please do not send sensitive health or medical information through the website contact forms unless we specifically ask you to do so through an appropriate secure channel.

3. How we collect personal data

We collect personal data directly from you when you submit information through our website forms.

Our website forms are operated through Webflow, which is used to host and manage form submissions. Webflow may process personal data on our behalf as a service provider.

We may also receive basic technical information when you visit the website, such as your IP address, browser type, device information, pages visited and time of access. This type of information may be processed automatically by our website hosting provider for security, reliability, troubleshooting and website operation purposes.

4. Why we use your personal data

We use personal data collected through the website for the following purposes:

  • to respond to your enquiry;
  • to communicate with you about MoleSense and our activities;
  • to manage business, partnership, media, investor or general contact requests;
  • to operate, maintain and secure the website;
  • to keep appropriate records of communications;
  • to comply with legal obligations, if applicable.

We do not sell your personal data.

5. Legal basis for processing

Where required by applicable law, we rely on one or more of the following legal bases:

  • your consent, where you choose to submit information through a form;
  • our legitimate interests, including responding to enquiries, operating the website, protecting our systems and managing business communications;
  • pre-contractual or contractual necessity, where your enquiry relates to a possible business relationship, collaboration or service;
  • legal obligations, where we are required to retain or disclose information by law.

6. Cookies and similar technologies

Our website may use cookies or similar technologies that are necessary for the operation, security and functionality of the website.

Based on our current setup, we do not use advertising cookies, tracking pixels or third-party analytics tools through the website. If this changes, we will update this Privacy Policy and, where required, request appropriate consent.

You can usually manage or disable cookies through your browser settings. Please note that disabling certain cookies may affect the functionality of the website.

7. Webflow and service providers

We use Webflow to operate the website and process website form submissions.

Webflow and other technical service providers may process personal data only to the extent necessary to provide hosting, form management, security, maintenance and related website services.

Some service providers may process data outside Switzerland, the European Economic Area or the United Kingdom. Where required by applicable law, we rely on appropriate safeguards for international transfers, such as adequacy decisions, contractual protections or other lawful transfer mechanisms.

8. Sharing of personal data

We may share personal data with:

  • website hosting and form-management providers, including Webflow;
  • technical service providers who help us operate and secure the website;
  • professional advisers, where necessary;
  • authorities, courts or regulators, where required by law.

We do not share website form data with external organisations for marketing or advertising purposes.

9. International visitors

This website may be accessed globally. MoleSense is based in Switzerland, and your personal data may be processed in Switzerland and in other countries where our service providers operate.

If you access the website from outside Switzerland, your personal data may be transferred to and processed in a country that may have different data protection laws from those in your country of residence.

10. How long we keep personal data

We keep personal data only for as long as necessary for the purposes described in this Privacy Policy.

As a general rule:

  • contact form submissions are kept for as long as necessary to respond to the enquiry and manage any resulting relationship;
  • business correspondence may be kept for a reasonable period for record-keeping, follow-up and legal purposes;
  • technical logs may be kept for a limited period for security, troubleshooting and website operation purposes.

Where a longer retention period is required by law, we may keep the relevant data for that longer period.

When personal data is no longer needed, we will delete it or anonymise it where reasonably possible.

11. Security

We take reasonable technical and organisational measures to protect personal data against unauthorised access, loss, misuse, alteration or disclosure.

However, no website or internet transmission is completely secure. You should avoid submitting sensitive information through general website forms.

12. Your rights

Depending on where you are located and which data protection laws apply, you may have the right to:

  • request access to your personal data;
  • request correction of inaccurate or incomplete personal data;
  • request deletion of your personal data;
  • object to or restrict certain processing;
  • withdraw consent where processing is based on consent;
  • request a copy of your personal data in a portable format, where applicable;
  • lodge a complaint with a competent data protection authority.

To exercise your rights, please contact us at contact@molesense.ch.

If you are located in Switzerland, you may also contact the Federal Data Protection and Information Commissioner (FDPIC). If you are located in the EU, EEA or UK, you may have the right to contact your local data protection authority.

13. Third-party links

Our website may contain links to third-party websites or services. We are not responsible for the privacy practices, content or security of those third-party websites. We encourage you to read their privacy policies before providing personal data to them.

14. Medical and health information

The information on our website is provided for general informational purposes only. The website does not provide medical advice, diagnosis or treatment.

We do not currently collect health data, patient data, biomarker data, wearable-device data, app data, product usage data or clinical data through this website.

If MoleSense later offers products, applications, clinical services, research studies or other activities involving health-related personal data, we will provide a separate or updated privacy notice describing that processing.

15. Changes to this Privacy Policy

We may update this Privacy Policy from time to time. Any changes will be posted on this page with an updated “Last updated” date.

We encourage you to review this Privacy Policy periodically.

16. Contact

For questions about this Privacy Policy or how we process personal data, please contact:

MoleSense Sàrl
Route de la Corniche 5
1066 Epalinges
Switzerland

Email: contact@molesense.ch

Technology
1
Custom Electronics
2
Molecular Biosensing
3
System Design
4
Analytics & AI
MoleSense develops application-specific electronics tailored for low-power, high-precision molecular sensing. Our custom ICs and embedded systems enable continuous biomarker measurement and reliable wireless data transmission, without the burden of frequent recharging or user intervention.

By optimising every layer of the electronics stack, from sensing interfaces to power management, we ensure that complex molecular data can be captured accurately, efficiently, and consistently over extended periods of real-world use.
MoleSense combines DNA-based biosensors with epidermal microfluidics to enable targeted, on-demand sweat analysis. Our patent-pending approach overcomes the limitations of passive sweat collection by allowing controlled sampling precisely when molecular information is needed.

By extracting and analysing sweat in a precise, repeatable way, we can reliably measure clinically relevant hormonal and inflammatory biomarkers through a non-invasive interface. This unlocks continuous access to the body’s chemistry without breaking the skin.
Our technology is built as a fully integrated wearable system, designed with patients in mind from day one. From materials and form factor to data transmission and device stability, every element is engineered to support continuous, real-world use without disrupting daily life.

By prioritising comfort, simplicity, and reliability, we ensure that advanced molecular monitoring fits naturally into everyday routines. The result is a seamless product experience that delivers high-quality molecular data while remaining comfortable, secure, and easy to use for both patients and clinicians.   
MoleSense uses data-driven analytics to interpret longitudinal hormone and biomarker trends at the individual level. By modelling personalised biological baselines, we can identify meaningful deviations from normal variation over time.

This approach helps highlight emerging patterns in molecular data that may be clinically relevant, supporting earlier insight and more informed decision-making. Rather than relying on isolated measurements, clinicians gain a clearer, longitudinal view of how a patient’s molecular health is evolving.     
Clinical Impact

Where continuous molecular insight can make the greatest difference

Across women’s health, many critical biological changes happen between clinical visits. Hormonal and inflammatory dynamics evolve continuously while care is often guided by isolated measurements and delayed signals. MoleSense brings continuous, non-invasive molecular monitoring into areas where earlier insight can transform outcomes.

Many pregnancy complications are driven by biochemical changes that emerge before clinical symptoms appear.

 Pregnancy-related risks such as infection, inflammation, and preterm labour often develop at the molecular level long before they become clinically visible. Traditional monitoring focuses on physiological signals and episodic testing, leaving critical biological changes unseen.

By enabling continuous hormonal and inflammatory insight, MoleSense supports earlier risk detection, improved management and stratification of preterm and stillbirth risks, and more informed clinical decisions. This molecular visibility also enables more personalised treatments, targeted nutrition and lifestyle guidance, reduced maternal stress through clearer monitoring, and earlier identification of postpartum mental health challenges—supporting healthier outcomes for both mother and baby.
- World Health Organisation (2023)

Reproductive hormone dynamics are complex, yet clinical decisions are often based on limited snapshots.

Fertility care relies on understanding precise hormonal timing and balance, yet traditional methods such as temperature tracking or sporadic hormone measurements offer only partial, momentary insight. These approaches can miss important fluctuations that influence ovulation, cycle regularity, and treatment response.

By enabling continuous ovarian hormone monitoring, MoleSense provides clinicians with a complete, longitudinal view of reproductive physiology. This supports improved treatment timing for assisted reproduction, clearer identification of hormonal irregularities, and more informed clinical decisions across fertility care pathways. Greater biological visibility can also reduce uncertainty for patients, helping to ease stress during an often emotionally demanding process.
- World Health Organisation (2025)

Menopause care often treats symptoms, not the underlying biology.

Menopause is not a single event, but a prolonged biological transition driven by evolving hormonal dynamics. These changes influence cardiovascular risk, bone health, metabolism, sleep, and mental wellbeing. However, clinical care often relies on symptom reporting rather than objective biological trends.

By enabling continuous hormone monitoring, MoleSense makes it possible to track how hormonal shifts unfold over time. This supports more precise treatment planning, clearer evaluation of hormone therapies, and earlier identification of emerging health risks—helping clinicians manage menopause as a dynamic physiological process, not just a collection of symptoms.
-The Menopause Society (2024)

Too many postpartum concerns are dismissed because they lack objective data.

After childbirth, women experience profound hormonal, inflammatory, and emotional changes that continue long after routine clinical follow-up has ended. Many reports feeling unheard when symptoms are difficult to quantify or fall outside standard checklists.

By providing continuous molecular insight from pregnancy through postpartum, MoleSense creates an objective biological record of each individual’s recovery journey. This longitudinal view helps distinguish expected changes from concerning deviations, supports more informed clinical conversations, and enables earlier, data-driven intervention.
- World Health Organisation (2023)

“Roughly 1 in 10 babies (about 13.4 million in 2020) are born preterm globally”

- World Health Organisation (2023)

Pregnancy

Continuous hormone and inflammation monitoring can help clinicians spot deviation earlier, triage risk faster, and support preventative interventions to reduce avoidable complications and late discovery.

“Approximately one in every six people experience infertility in their lifetime.”

- World Health Organisation (2025)

Fertility

By monitoring ovarian hormone dynamics over time, we can help build clearer ovulation and cycle profiles, support earlier escalation when needed, and provide objective tracking alongside fertility care.

“Less than one-fourth (22.7%) of women with severe menopause symptoms had them documented”

-The Menopause Society (2024)

Menopause

Menopause is multi-system and highly individual. Continuous hormone insight can support more personalised symptom management, therapy tracking, and a clearer understanding of what’s changing.

“More than a third of women experience lasting health problems after childbirth.”

- World Health Organisation (2023)

Postpartum

The period includes a wide range of physical and mental health changes that can evolve between appointments. We can enable the establishing of an individual recovery baseline, then flag unusual shifts earlier supporting more timely intervention when needed.
Our Collaborators